CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

New England Journal of Medicine
Original article

Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials

Phase 3OveporextonNeutral
AI Analysis

Summary

Oveporexton Phase 3 trial results for Narcolepsy Type 1 published in New England Journal of Medicine. Article title only; specific efficacy/safety data not provided in source text.

Clinical Trial Data

Phase

Phase 3

Importance:7/10
Sentiment:
0.00
Phase 3NarcolepsyNEJM Publication
Related Companies

Read the original article

Published by New England Journal of Medicine on September 9, 2026 12:00 PM

Read Original